Original document(159 pages)  中文版
    A compound having the activity of glucokinase activation and being useful for the prevention or treatment of diabetes, etc., represented by the formula: (I) [wherein X is a nitrogen atom, etc.; Y is an oxygen atom, etc.; R<1> is an optionally substituted 5 to 6-membered heteroaryl group, etc.; R<2> is a hydrogen atom or a fluorine atom; and the ring A is an optionally substituted monocyclic or bicyclic heteroaryl group of the formula: (II) ], or a pharmacologically acceptable salt thereof.
Application Number
申请号		 200580009447 Application Date
申请日		 2005.03.23
Title 名称 Substituted quinazoline or pyridopyrimidine derivative
Publication Number
公开号		 1934100 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D401/14;A61K31/513;A61K31/517;A61K31/519;A61K45/00;A61P3/04;A61P3/10;A61P9/10;A61P13/12;A61P25/28;A61P27/02;A61P43/00;C07D403/12;C07D403/14;C07D405/14;C07D413/12;C07D417/14;C07D471/04;C07D513/04;C07D519/00
Applicant(s) Name
申请人		 Banyu Pharma Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 sunxiu wu libing ai
More information 更  多  信  息


 Related patents information
Novel 2-pyridinecarboxamide derivatives
Novel substituted imidazole derivatives
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.